Structure

Physi-Chem Properties

Molecular Weight:  582.25
Volume:  589.34
LogP:  3.542
LogD:  1.579
LogS:  -4.927
# Rotatable Bonds:  9
TPSA:  146.41
# H-Bond Aceptor:  10
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.283
Synthetic Accessibility Score:  5.413
Fsp3:  0.531
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.016
MDCK Permeability:  1.2752115253533702e-05
Pgp-inhibitor:  1.0
Pgp-substrate:  0.003
Human Intestinal Absorption (HIA):  0.062
20% Bioavailability (F20%):  0.999
30% Bioavailability (F30%):  0.931

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.236
Plasma Protein Binding (PPB):  91.99263763427734%
Volume Distribution (VD):  2.16
Pgp-substrate:  5.6945109367370605%

ADMET: Metabolism

CYP1A2-inhibitor:  0.026
CYP1A2-substrate:  0.104
CYP2C19-inhibitor:  0.94
CYP2C19-substrate:  0.462
CYP2C9-inhibitor:  0.964
CYP2C9-substrate:  0.024
CYP2D6-inhibitor:  0.191
CYP2D6-substrate:  0.031
CYP3A4-inhibitor:  0.947
CYP3A4-substrate:  0.907

ADMET: Excretion

Clearance (CL):  3.24
Half-life (T1/2):  0.871

ADMET: Toxicity

hERG Blockers:  0.224
Human Hepatotoxicity (H-HT):  0.835
Drug-inuced Liver Injury (DILI):  0.828
AMES Toxicity:  0.538
Rat Oral Acute Toxicity:  0.995
Maximum Recommended Daily Dose:  0.949
Skin Sensitization:  0.333
Carcinogencity:  0.576
Eye Corrosion:  0.004
Eye Irritation:  0.022
Respiratory Toxicity:  0.952

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC173544

Natural Product ID:  NPC173544
Common Name*:   Granaxylocarpin B
IUPAC Name:   [(R)-[(1R,5R,8aR)-1-(furan-3-yl)-5-hydroxy-8a-methyl-3,6-dioxo-7,8-dihydro-1H-isochromen-5-yl]-[(4R,5R)-4-(2-methoxy-2-oxoethyl)-3,3,5-trimethyl-6-oxocyclohexen-1-yl]methyl] (E)-2-methylbut-2-enoate
Synonyms:  
Standard InCHIKey:  ZBJPDPDKXYNWFV-PQAYMIJJSA-N
Standard InCHI:  InChI=1S/C32H38O10/c1-8-17(2)29(37)42-28(20-15-30(4,5)21(13-24(34)39-7)18(3)26(20)36)32(38)22-14-25(35)41-27(19-10-12-40-16-19)31(22,6)11-9-23(32)33/h8,10,12,14-16,18,21,27-28,38H,9,11,13H2,1-7H3/b17-8+/t18-,21-,27+,28-,31-,32+/m1/s1
SMILES:  C/C=C(/C(=O)O[C@@H]([C@@]1(O)C(=O)CC[C@@]2(C1=CC(=O)O[C@H]2c1cocc1)C)C1=CC(C)(C)[C@@H]([C@H](C1=O)C)CC(=O)OC)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL390119
PubChem CID:   16216542
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0001986] Tricarboxylic acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO28813 Xylocarpus granatum Species Meliaceae Eukaryota n.a. rind n.a. DOI[10.1002/hlca.200800177]
NPO28813 Xylocarpus granatum Species Meliaceae Eukaryota seeds n.a. n.a. PMID[17323995]
NPO28813 Xylocarpus granatum Species Meliaceae Eukaryota n.a. bark n.a. PMID[17450509]
NPO28813 Xylocarpus granatum Species Meliaceae Eukaryota seed kernels n.a. n.a. PMID[19908853]
NPO28813 Xylocarpus granatum Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[20411928]
NPO28813 Xylocarpus granatum Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[31895570]
NPO28813 Xylocarpus granatum Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT168 Cell Line P388 Mus musculus IC50 = 4900.0 nM PMID[528401]
NPT81 Cell Line A549 Homo sapiens IC50 > 10000.0 nM PMID[528401]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC173544 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9932 High Similarity NPC469485
0.9671 High Similarity NPC329938
0.9605 High Similarity NPC477402
0.9539 High Similarity NPC477403
0.9419 High Similarity NPC469849
0.9419 High Similarity NPC470940
0.9359 High Similarity NPC470875
0.9355 High Similarity NPC292389
0.9355 High Similarity NPC469338
0.9342 High Similarity NPC264943
0.9295 High Similarity NPC276551
0.929 High Similarity NPC193798
0.929 High Similarity NPC69028
0.9231 High Similarity NPC477405
0.9226 High Similarity NPC25255
0.9177 High Similarity NPC173516
0.9177 High Similarity NPC472282
0.9167 High Similarity NPC263432
0.9119 High Similarity NPC471397
0.9119 High Similarity NPC160651
0.9097 High Similarity NPC472283
0.9097 High Similarity NPC45101
0.9097 High Similarity NPC261597
0.9097 High Similarity NPC36655
0.9091 High Similarity NPC281258
0.9091 High Similarity NPC214541
0.9091 High Similarity NPC44675
0.9085 High Similarity NPC44577
0.9057 High Similarity NPC472775
0.9057 High Similarity NPC472774
0.9051 High Similarity NPC476858
0.9051 High Similarity NPC123088
0.9051 High Similarity NPC476857
0.9051 High Similarity NPC476856
0.9045 High Similarity NPC82851
0.9012 High Similarity NPC471437
0.8987 High Similarity NPC472773
0.8987 High Similarity NPC224394
0.8987 High Similarity NPC663
0.8981 High Similarity NPC472653
0.8974 High Similarity NPC249021
0.8968 High Similarity NPC469336
0.8938 High Similarity NPC476861
0.8938 High Similarity NPC476853
0.8938 High Similarity NPC476850
0.8931 High Similarity NPC476860
0.8924 High Similarity NPC5079
0.8924 High Similarity NPC472771
0.8917 High Similarity NPC237155
0.8917 High Similarity NPC307383
0.891 High Similarity NPC60973
0.8903 High Similarity NPC178932
0.8903 High Similarity NPC30222
0.8902 High Similarity NPC478177
0.8875 High Similarity NPC23387
0.8868 High Similarity NPC51568
0.8868 High Similarity NPC234660
0.8861 High Similarity NPC191828
0.8854 High Similarity NPC167142
0.8854 High Similarity NPC472776
0.8854 High Similarity NPC286722
0.8854 High Similarity NPC472772
0.8854 High Similarity NPC187149
0.8854 High Similarity NPC472778
0.8854 High Similarity NPC472777
0.8846 High Similarity NPC35000
0.8846 High Similarity NPC469850
0.8831 High Similarity NPC159927
0.8831 High Similarity NPC46551
0.8831 High Similarity NPC469335
0.8812 High Similarity NPC470182
0.8805 High Similarity NPC149896
0.8805 High Similarity NPC470939
0.8805 High Similarity NPC200782
0.8797 High Similarity NPC475967
0.8797 High Similarity NPC475295
0.8797 High Similarity NPC262872
0.8797 High Similarity NPC473473
0.879 High Similarity NPC263265
0.879 High Similarity NPC209364
0.8782 High Similarity NPC282445
0.878 High Similarity NPC94763
0.8765 High Similarity NPC472652
0.8758 High Similarity NPC475779
0.8758 High Similarity NPC250228
0.8758 High Similarity NPC472141
0.875 High Similarity NPC302369
0.875 High Similarity NPC198047
0.875 High Similarity NPC39986
0.875 High Similarity NPC288602
0.875 High Similarity NPC88841
0.875 High Similarity NPC134254
0.8742 High Similarity NPC305016
0.8742 High Similarity NPC470789
0.8742 High Similarity NPC335761
0.8727 High Similarity NPC469633
0.8718 High Similarity NPC75906
0.8718 High Similarity NPC469503
0.871 High Similarity NPC196864
0.871 High Similarity NPC477404
0.8704 High Similarity NPC472651
0.8704 High Similarity NPC478179
0.8704 High Similarity NPC473766
0.8704 High Similarity NPC473753
0.8696 High Similarity NPC271657
0.8693 High Similarity NPC346
0.8693 High Similarity NPC262198
0.8688 High Similarity NPC207978
0.8688 High Similarity NPC211777
0.8688 High Similarity NPC188649
0.8688 High Similarity NPC290400
0.8688 High Similarity NPC96443
0.8688 High Similarity NPC18347
0.8684 High Similarity NPC137295
0.8679 High Similarity NPC472779
0.8671 High Similarity NPC107646
0.8671 High Similarity NPC126723
0.8667 High Similarity NPC469576
0.8667 High Similarity NPC90296
0.8667 High Similarity NPC471632
0.8667 High Similarity NPC236004
0.8659 High Similarity NPC160818
0.8659 High Similarity NPC169299
0.865 High Similarity NPC271235
0.8642 High Similarity NPC149945
0.8642 High Similarity NPC478178
0.8642 High Similarity NPC121995
0.8636 High Similarity NPC470941
0.8634 High Similarity NPC476197
0.8625 High Similarity NPC287559
0.8625 High Similarity NPC475381
0.8616 High Similarity NPC197137
0.8616 High Similarity NPC470118
0.8616 High Similarity NPC299038
0.8608 High Similarity NPC92979
0.8608 High Similarity NPC476262
0.8599 High Similarity NPC476201
0.8599 High Similarity NPC147168
0.8598 High Similarity NPC82602
0.8589 High Similarity NPC100333
0.858 High Similarity NPC146991
0.8571 High Similarity NPC117986
0.8571 High Similarity NPC68848
0.8571 High Similarity NPC18986
0.8562 High Similarity NPC142113
0.8562 High Similarity NPC476944
0.8545 High Similarity NPC285227
0.8545 High Similarity NPC159232
0.8544 High Similarity NPC57998
0.8537 High Similarity NPC472765
0.8537 High Similarity NPC472766
0.8537 High Similarity NPC296558
0.8535 High Similarity NPC272590
0.8535 High Similarity NPC18135
0.8529 High Similarity NPC242068
0.8529 High Similarity NPC247563
0.8526 High Similarity NPC69647
0.8526 High Similarity NPC125182
0.8519 High Similarity NPC165218
0.8519 High Similarity NPC419
0.8519 High Similarity NPC472139
0.8519 High Similarity NPC469846
0.8516 High Similarity NPC255414
0.85 High Similarity NPC88007
0.8497 Intermediate Similarity NPC267632
0.8485 Intermediate Similarity NPC470995
0.8481 Intermediate Similarity NPC33938
0.8476 Intermediate Similarity NPC476224
0.8476 Intermediate Similarity NPC270312
0.8476 Intermediate Similarity NPC472764
0.8471 Intermediate Similarity NPC476122
0.8467 Intermediate Similarity NPC310830
0.8466 Intermediate Similarity NPC261184
0.8457 Intermediate Similarity NPC470792
0.8457 Intermediate Similarity NPC472767
0.8457 Intermediate Similarity NPC197596
0.8456 Intermediate Similarity NPC158525
0.8447 Intermediate Similarity NPC473368
0.8447 Intermediate Similarity NPC475226
0.8442 Intermediate Similarity NPC86935
0.8438 Intermediate Similarity NPC41880
0.8431 Intermediate Similarity NPC121158
0.8424 Intermediate Similarity NPC327922
0.8421 Intermediate Similarity NPC105395
0.8418 Intermediate Similarity NPC116717
0.8415 Intermediate Similarity NPC214600
0.8415 Intermediate Similarity NPC97574
0.8415 Intermediate Similarity NPC93172
0.8411 Intermediate Similarity NPC476943
0.8411 Intermediate Similarity NPC220094
0.8408 Intermediate Similarity NPC472654
0.8408 Intermediate Similarity NPC329180
0.8408 Intermediate Similarity NPC195325
0.8405 Intermediate Similarity NPC285567
0.8397 Intermediate Similarity NPC221809
0.8393 Intermediate Similarity NPC262386
0.8387 Intermediate Similarity NPC34056
0.8385 Intermediate Similarity NPC195954
0.8385 Intermediate Similarity NPC194499
0.8383 Intermediate Similarity NPC469848

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC173544 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.858 High Similarity NPD8434 Phase 2
0.8261 Intermediate Similarity NPD5760 Phase 2
0.8261 Intermediate Similarity NPD5761 Phase 2
0.8061 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7657 Intermediate Similarity NPD6764 Approved
0.7657 Intermediate Similarity NPD6765 Approved
0.7574 Intermediate Similarity NPD7075 Discontinued
0.7516 Intermediate Similarity NPD4628 Phase 3
0.75 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD6784 Approved
0.7486 Intermediate Similarity NPD6785 Approved
0.744 Intermediate Similarity NPD6801 Discontinued
0.7425 Intermediate Similarity NPD6599 Discontinued
0.736 Intermediate Similarity NPD6559 Discontinued
0.7353 Intermediate Similarity NPD5402 Approved
0.7347 Intermediate Similarity NPD8404 Phase 2
0.7294 Intermediate Similarity NPD7819 Suspended
0.7262 Intermediate Similarity NPD3226 Approved
0.7251 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7251 Intermediate Similarity NPD3817 Phase 2
0.7246 Intermediate Similarity NPD920 Approved
0.7246 Intermediate Similarity NPD5403 Approved
0.7241 Intermediate Similarity NPD1247 Approved
0.7225 Intermediate Similarity NPD919 Approved
0.7198 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7195 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7191 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7189 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD7411 Suspended
0.7169 Intermediate Similarity NPD6799 Approved
0.7158 Intermediate Similarity NPD8150 Discontinued
0.7135 Intermediate Similarity NPD3818 Discontinued
0.7134 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD5401 Approved
0.7126 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD4380 Phase 2
0.7117 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD3882 Suspended
0.7088 Intermediate Similarity NPD8312 Approved
0.7088 Intermediate Similarity NPD8313 Approved
0.7069 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7022 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD1471 Phase 3
0.7011 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.6994 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6989 Remote Similarity NPD5494 Approved
0.6983 Remote Similarity NPD7473 Discontinued
0.6971 Remote Similarity NPD3749 Approved
0.6957 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6944 Remote Similarity NPD7799 Discontinued
0.6944 Remote Similarity NPD7893 Clinical (unspecified phase)
0.694 Remote Similarity NPD7808 Phase 3
0.694 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6937 Remote Similarity NPD3268 Approved
0.6936 Remote Similarity NPD1934 Approved
0.6928 Remote Similarity NPD2800 Approved
0.6927 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6927 Remote Similarity NPD6166 Phase 2
0.6927 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6923 Remote Similarity NPD2534 Approved
0.6923 Remote Similarity NPD2533 Approved
0.6923 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6923 Remote Similarity NPD2532 Approved
0.6897 Remote Similarity NPD2801 Approved
0.689 Remote Similarity NPD7033 Discontinued
0.6885 Remote Similarity NPD7685 Pre-registration
0.6885 Remote Similarity NPD7251 Discontinued
0.6865 Remote Similarity NPD8407 Phase 2
0.686 Remote Similarity NPD7458 Discontinued
0.6854 Remote Similarity NPD8127 Discontinued
0.6848 Remote Similarity NPD2796 Approved
0.6848 Remote Similarity NPD1551 Phase 2
0.6832 Remote Similarity NPD2313 Discontinued
0.6831 Remote Similarity NPD6797 Phase 2
0.6826 Remote Similarity NPD1243 Approved
0.6824 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6818 Remote Similarity NPD7768 Phase 2
0.6816 Remote Similarity NPD6232 Discontinued
0.6813 Remote Similarity NPD5844 Phase 1
0.6813 Remote Similarity NPD7054 Approved
0.681 Remote Similarity NPD6355 Discontinued
0.6809 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6807 Remote Similarity NPD2346 Discontinued
0.6805 Remote Similarity NPD7236 Approved
0.6793 Remote Similarity NPD8368 Discontinued
0.6788 Remote Similarity NPD2799 Discontinued
0.6786 Remote Similarity NPD3750 Approved
0.6784 Remote Similarity NPD1512 Approved
0.6784 Remote Similarity NPD6273 Approved
0.678 Remote Similarity NPD7907 Approved
0.6778 Remote Similarity NPD3926 Phase 2
0.6776 Remote Similarity NPD7472 Approved
0.6776 Remote Similarity NPD7074 Phase 3
0.6766 Remote Similarity NPD970 Clinical (unspecified phase)
0.6766 Remote Similarity NPD1549 Phase 2
0.6758 Remote Similarity NPD3751 Discontinued
0.6747 Remote Similarity NPD6100 Approved
0.6747 Remote Similarity NPD6099 Approved
0.6735 Remote Similarity NPD7435 Discontinued
0.6708 Remote Similarity NPD6832 Phase 2
0.6707 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6707 Remote Similarity NPD2344 Approved
0.6707 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6707 Remote Similarity NPD447 Suspended
0.6705 Remote Similarity NPD7239 Suspended
0.6701 Remote Similarity NPD8285 Discontinued
0.6687 Remote Similarity NPD1510 Phase 2
0.6687 Remote Similarity NPD4308 Phase 3
0.6687 Remote Similarity NPD5647 Approved
0.6686 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6684 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7095 Approved
0.6667 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6667 Remote Similarity NPD1511 Approved
0.6667 Remote Similarity NPD6959 Discontinued
0.6648 Remote Similarity NPD6234 Discontinued
0.6648 Remote Similarity NPD37 Approved
0.6648 Remote Similarity NPD2403 Approved
0.6647 Remote Similarity NPD2935 Discontinued
0.6647 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6647 Remote Similarity NPD6190 Approved
0.6646 Remote Similarity NPD1608 Approved
0.6635 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6632 Remote Similarity NPD8360 Approved
0.6632 Remote Similarity NPD8361 Approved
0.6629 Remote Similarity NPD4966 Approved
0.6629 Remote Similarity NPD4967 Phase 2
0.6629 Remote Similarity NPD4965 Approved
0.6625 Remote Similarity NPD3267 Approved
0.6625 Remote Similarity NPD2797 Approved
0.6625 Remote Similarity NPD3266 Approved
0.6625 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6617 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6617 Remote Similarity NPD7874 Approved
0.6607 Remote Similarity NPD6004 Phase 3
0.6607 Remote Similarity NPD6005 Phase 3
0.6607 Remote Similarity NPD5762 Approved
0.6607 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6607 Remote Similarity NPD5763 Approved
0.6607 Remote Similarity NPD6002 Phase 3
0.6607 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6602 Remote Similarity NPD4111 Phase 1
0.6602 Remote Similarity NPD4665 Approved
0.6593 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6588 Remote Similarity NPD8166 Discontinued
0.6587 Remote Similarity NPD3748 Approved
0.6585 Remote Similarity NPD6233 Phase 2
0.6582 Remote Similarity NPD6781 Approved
0.6582 Remote Similarity NPD6776 Approved
0.6582 Remote Similarity NPD6782 Approved
0.6582 Remote Similarity NPD6780 Approved
0.6582 Remote Similarity NPD6779 Approved
0.6582 Remote Similarity NPD6777 Approved
0.6582 Remote Similarity NPD6778 Approved
0.6581 Remote Similarity NPD9092 Discovery
0.657 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6566 Remote Similarity NPD7698 Approved
0.6566 Remote Similarity NPD7696 Phase 3
0.6566 Remote Similarity NPD6653 Approved
0.6566 Remote Similarity NPD6651 Approved
0.6566 Remote Similarity NPD7697 Approved
0.6557 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6557 Remote Similarity NPD4575 Clinical (unspecified phase)
0.655 Remote Similarity NPD2309 Approved
0.655 Remote Similarity NPD3887 Approved
0.655 Remote Similarity NPD2354 Approved
0.6545 Remote Similarity NPD8435 Approved
0.6541 Remote Similarity NPD9717 Approved
0.6538 Remote Similarity NPD3787 Discontinued
0.6538 Remote Similarity NPD6808 Phase 2
0.6533 Remote Similarity NPD8319 Approved
0.6533 Remote Similarity NPD7871 Phase 2
0.6533 Remote Similarity NPD7870 Phase 2
0.6533 Remote Similarity NPD8320 Phase 1
0.6524 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6524 Remote Similarity NPD3764 Approved
0.6524 Remote Similarity NPD6798 Discontinued
0.6517 Remote Similarity NPD7972 Discontinued
0.6517 Remote Similarity NPD7701 Phase 2
0.6517 Remote Similarity NPD1465 Phase 2
0.6517 Remote Similarity NPD8455 Phase 2
0.6515 Remote Similarity NPD3057 Approved
0.6506 Remote Similarity NPD230 Phase 1
0.6502 Remote Similarity NPD7801 Approved
0.6497 Remote Similarity NPD4107 Approved
0.6491 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6491 Remote Similarity NPD4110 Phase 3
0.6486 Remote Similarity NPD2163 Approved
0.6486 Remote Similarity NPD7228 Approved
0.6485 Remote Similarity NPD8032 Phase 2
0.6484 Remote Similarity NPD7199 Phase 2
0.6481 Remote Similarity NPD2798 Approved
0.6471 Remote Similarity NPD5953 Discontinued
0.6467 Remote Similarity NPD1607 Approved
0.6463 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6456 Remote Similarity NPD17 Approved
0.6452 Remote Similarity NPD7286 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data